Posts Tagged ‘liver cancer’

Can Coffee Reduce the Risk of Liver Cancer?

Wednesday, October 30th, 2013

logo1267406_mdA new study published in Clinical Gastroenterology and Hepatology concluded coffee consumption reduces the risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent. The researchers said “Our research confirmed past claims that coffee is good for your health, and particularly the liver.”

A meta-analysis of articles published between 1996 and 2012 was carried out and 16 high quality studies with a total of 3,153 cases was selected for analysis. There was consistency of results across studies, time periods, and populations but it was difficult to establish whether the association between coffee drinking and HCC found was causal or if the relationship was a result of patients with liver and digestive diseases voluntarily reducing their coffee intake. Researchers said “It remains unclear whether coffee drinking has an additional role in liver cancer prevention.” They continue on to say that the role of coffee consumption would be limited compared to what is available through current measures such as hepatitis B virus vaccination, control of hepatitis C virus transmission and reduction of alcohol drinking that in total an avoid more than 90 percent of primary liver cancers worldwide.

Do Soybeans have Anti-Cancer Properties?

Friday, March 29th, 2013

logo1267406_mdA new study published in Food Research International by Elsevier concluded that protein found in soybeans could prohibit the growth of colon, liver and lung cancers. Soybean meal is a bi-product following extraction of oil from soybean seeds that is rich in protein making up around 40of the nutritional value of the seed depending upon the line. It can contain  high oleic acid- a monounsaturated omega 9 fatty acid.

The study looked at the role of soybeans in preventing cancer. Using a variety of soybeans that were high in oleic acid and protein. researchers monitored the bio activity between peptides derived from the meals of soybeans and various human cancer cell types.

The study showed that peptides derived from soybean meal significantly inhibited cell growth by 73% for colon cancer, 70% for liver cancer, and 69% for lung cancer. This showed that the selected high oleic acid soybean lines have a potential nutraceutical affect in helping to reduce the growth of these types of cancer cells.

 

 

 

Can Vitamin E Reduce Liver Cancer Risk?

Friday, July 27th, 2012

A new study published in the Journal of the National Cancer Institute concluded that high consumption of vitamin E  from diet or supplements may lower the risk of liver cancer. Although we rarely hear about liver cancer, it is the third most common cause of cancer mortality in the world and a large percentage of these occurs in developing countries.

Data was analyzed from 132,737 people in China who were enrolled in the Shanghai Women’s Health Study from 1997 to 2000, or the Shanghai Men’s Health Study from 2002 to 2006.

In-person interviews to gather data on dietary habits were conducted using validated food-frequency questionaires.  Questions were included on how often participants ate some of the most commonly consumed Shanghai foods and whether or not they took vitamin supplements. Liver cancer risk was then determined between those with high and low vitamin E intake.

There were 267 liver cancer patients (118 women and 149 men) diagnosed between 2 years after study enrollment and an average of 10.9 years for women and 5.5 years for men. Researchers found that vitamin E intake from both food and supplements were associated with a lower risk of liver cancer. The researchers said ” We found a clear, inverse dose-response relationship between vitamin E intake and liver cancer risk.” “Overall, the take home message is that the high intake of vitamin E either from diet or supplements was related to lower risk of liver cancer in middle -aged or older people from China.”  Conversely, those who had the highest intake of vitamin C intake from supplements who had a family history of liver disease or self-reported liver disease were more likely to develop liver cancer.

Lose Weight to Reduce Cancer Risk?

Friday, February 12th, 2010

logo1267406_md

Research published in the January 22 issue of Cell confirmed that obesity in mice increased the risk of cancer especially liver cancer. In their study the researchers gave 2 week old mice DEN ( a chemical carcinogen) and divided them into two groups. One group was fed a normal diet that was relatively low in fat and the other group a diet high in fat. The high fat group developed more liver cancer than the normal diet group. To further confirm the link between obesity and liver cancer they gave 2 week old mice DEN that were fed a normal diet but were prone to obesity. This group also developed more liver cancer so the researchers concluded that it was not necessarily the high fat diet but something about the obesity state. They also gave DEN to 3 month old mice on a high fat diet and they also developed more liver cancer. Usually mice on a standard diet given DEN at this age without the extra push of phenobarbitol do not develop liver cancer. But the obese mice developed liver cancer without the extra push of phenobarbitol. The researchers traced the source of the obese cancer producing effect to a rise in inflammatory factors and obese mice lacking these did not show the same rise in liver cancer nor the same distribution of fat in the body. This study suggests that anti-inflammatory drugs used for rheumatoid arthritis and Crohn’s disease may also reduce the risk of cancer for those at high risk of liver cancer because of obesity. .